iTBS to Enhance Social Cognition in People With Psychosis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 18, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
SchizophreniaSchizo Affective DisorderSchizophreniform DisordersPsychosis Nos/Other
Interventions
DEVICE

iTBS (Active)

"The present study is a double-blind, randomized clinical trial that will examine if iTBS applied to DMPFC improves social cognitive performance compared to sham stimulation~DMPFC-iTBS will be administered using the MagPro R30 stimulator equipped with a Cool-B70 coil and Qooler fluid-cooling device (MagVenture, Farum, Denmark), positioned under MRI guidance using the Visor 2.0 system (Advanced Neuro Technologies Enschede, Netherlands)."

DEVICE

iTBS (Sham)

DMPFC-iTBS will be administered using the MagPro R30 stimulator equipped with a Cool-B70 coil and Qooler fluid-cooling device (MagVenture, Farum, Denmark), positioned under MRI guidance using the Visor 2.0 system (Advanced Neuro Technologies Enschede, Netherlands).

Trial Locations (1)

11004

RECRUITING

Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

Centre for Addiction and Mental Health

OTHER

collaborator

University of Maryland, Baltimore

OTHER

lead

Northwell Health

OTHER